img

Global Biopharma Buffer Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biopharma Buffer Market Research Report 2024

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
According to Mr Accuracy reports new survey, global Biopharma Buffer market is projected to reach US$ 1068.2 million in 2029, increasing from US$ 841 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biopharma Buffer market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharma Buffer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
Segment by Type
Phosphates Type
Acetates Type
TRIS Type
Others

Segment by Application


Research Institution
Pharmaceutical Industry
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Biopharma Buffer report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Biopharma Buffer Market Overview
1.1 Product Overview and Scope of Biopharma Buffer
1.2 Biopharma Buffer Segment by Type
1.2.1 Global Biopharma Buffer Market Value Comparison by Type (2024-2034)
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Biopharma Buffer Segment by Application
1.3.1 Global Biopharma Buffer Market Value by Application: (2024-2034)
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Global Biopharma Buffer Market Size Estimates and Forecasts
1.4.1 Global Biopharma Buffer Revenue 2018-2029
1.4.2 Global Biopharma Buffer Sales 2018-2029
1.4.3 Global Biopharma Buffer Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Biopharma Buffer Market Competition by Manufacturers
2.1 Global Biopharma Buffer Sales Market Share by Manufacturers (2018-2024)
2.2 Global Biopharma Buffer Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Biopharma Buffer Average Price by Manufacturers (2018-2024)
2.4 Global Biopharma Buffer Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Biopharma Buffer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biopharma Buffer, Product Type & Application
2.7 Biopharma Buffer Market Competitive Situation and Trends
2.7.1 Biopharma Buffer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biopharma Buffer Players Market Share by Revenue
2.7.3 Global Biopharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biopharma Buffer Retrospective Market Scenario by Region
3.1 Global Biopharma Buffer Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Biopharma Buffer Global Biopharma Buffer Sales by Region: 2018-2029
3.2.1 Global Biopharma Buffer Sales by Region: 2018-2024
3.2.2 Global Biopharma Buffer Sales by Region: 2024-2029
3.3 Global Biopharma Buffer Global Biopharma Buffer Revenue by Region: 2018-2029
3.3.1 Global Biopharma Buffer Revenue by Region: 2018-2024
3.3.2 Global Biopharma Buffer Revenue by Region: 2024-2029
3.4 North America Biopharma Buffer Market Facts & Figures by Country
3.4.1 North America Biopharma Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Biopharma Buffer Sales by Country (2018-2029)
3.4.3 North America Biopharma Buffer Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biopharma Buffer Market Facts & Figures by Country
3.5.1 Europe Biopharma Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Biopharma Buffer Sales by Country (2018-2029)
3.5.3 Europe Biopharma Buffer Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biopharma Buffer Market Facts & Figures by Country
3.6.1 Asia Pacific Biopharma Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Biopharma Buffer Sales by Country (2018-2029)
3.6.3 Asia Pacific Biopharma Buffer Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Biopharma Buffer Market Facts & Figures by Country
3.7.1 Latin America Biopharma Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Biopharma Buffer Sales by Country (2018-2029)
3.7.3 Latin America Biopharma Buffer Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biopharma Buffer Market Facts & Figures by Country
3.8.1 Middle East and Africa Biopharma Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Biopharma Buffer Sales by Country (2018-2029)
3.8.3 Middle East and Africa Biopharma Buffer Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biopharma Buffer Sales by Type (2018-2029)
4.1.1 Global Biopharma Buffer Sales by Type (2018-2024)
4.1.2 Global Biopharma Buffer Sales by Type (2024-2029)
4.1.3 Global Biopharma Buffer Sales Market Share by Type (2018-2029)
4.2 Global Biopharma Buffer Revenue by Type (2018-2029)
4.2.1 Global Biopharma Buffer Revenue by Type (2018-2024)
4.2.2 Global Biopharma Buffer Revenue by Type (2024-2029)
4.2.3 Global Biopharma Buffer Revenue Market Share by Type (2018-2029)
4.3 Global Biopharma Buffer Price by Type (2018-2029)
5 Segment by Application
5.1 Global Biopharma Buffer Sales by Application (2018-2029)
5.1.1 Global Biopharma Buffer Sales by Application (2018-2024)
5.1.2 Global Biopharma Buffer Sales by Application (2024-2029)
5.1.3 Global Biopharma Buffer Sales Market Share by Application (2018-2029)
5.2 Global Biopharma Buffer Revenue by Application (2018-2029)
5.2.1 Global Biopharma Buffer Revenue by Application (2018-2024)
5.2.2 Global Biopharma Buffer Revenue by Application (2024-2029)
5.2.3 Global Biopharma Buffer Revenue Market Share by Application (2018-2029)
5.3 Global Biopharma Buffer Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Avantor
6.1.1 Avantor Corporation Information
6.1.2 Avantor Description and Business Overview
6.1.3 Avantor Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Avantor Biopharma Buffer Product Portfolio
6.1.5 Avantor Recent Developments/Updates
6.2 Alfa Aesar (Thermo Fisher)
6.2.1 Alfa Aesar (Thermo Fisher) Corporation Information
6.2.2 Alfa Aesar (Thermo Fisher) Description and Business Overview
6.2.3 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Portfolio
6.2.5 Alfa Aesar (Thermo Fisher) Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Merck Biopharma Buffer Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Lonza
6.4.1 Lonza Corporation Information
6.4.2 Lonza Description and Business Overview
6.4.3 Lonza Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Lonza Biopharma Buffer Product Portfolio
6.4.5 Lonza Recent Developments/Updates
6.5 Bio-Rad
6.5.1 Bio-Rad Corporation Information
6.5.2 Bio-Rad Description and Business Overview
6.5.3 Bio-Rad Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Bio-Rad Biopharma Buffer Product Portfolio
6.5.5 Bio-Rad Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.6.4 BD Biopharma Buffer Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 GE Healthcare
6.6.1 GE Healthcare Corporation Information
6.6.2 GE Healthcare Description and Business Overview
6.6.3 GE Healthcare Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GE Healthcare Biopharma Buffer Product Portfolio
6.7.5 GE Healthcare Recent Developments/Updates
6.8 Promega Corporation
6.8.1 Promega Corporation Corporation Information
6.8.2 Promega Corporation Description and Business Overview
6.8.3 Promega Corporation Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Promega Corporation Biopharma Buffer Product Portfolio
6.8.5 Promega Corporation Recent Developments/Updates
6.9 Hamilton Company
6.9.1 Hamilton Company Corporation Information
6.9.2 Hamilton Company Description and Business Overview
6.9.3 Hamilton Company Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Hamilton Company Biopharma Buffer Product Portfolio
6.9.5 Hamilton Company Recent Developments/Updates
6.10 XZL BIO-TECHNOLOGY
6.10.1 XZL BIO-TECHNOLOGY Corporation Information
6.10.2 XZL BIO-TECHNOLOGY Description and Business Overview
6.10.3 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.10.4 XZL BIO-TECHNOLOGY Biopharma Buffer Product Portfolio
6.10.5 XZL BIO-TECHNOLOGY Recent Developments/Updates
6.11 SRL
6.11.1 SRL Corporation Information
6.11.2 SRL Biopharma Buffer Description and Business Overview
6.11.3 SRL Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
6.11.4 SRL Biopharma Buffer Product Portfolio
6.11.5 SRL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biopharma Buffer Industry Chain Analysis
7.2 Biopharma Buffer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biopharma Buffer Production Mode & Process
7.4 Biopharma Buffer Sales and Marketing
7.4.1 Biopharma Buffer Sales Channels
7.4.2 Biopharma Buffer Distributors
7.5 Biopharma Buffer Customers
8 Biopharma Buffer Market Dynamics
8.1 Biopharma Buffer Industry Trends
8.2 Biopharma Buffer Market Drivers
8.3 Biopharma Buffer Market Challenges
8.4 Biopharma Buffer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Biopharma Buffer Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Biopharma Buffer Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Biopharma Buffer Market Competitive Situation by Manufacturers in 2022
Table 4. Global Biopharma Buffer Sales (KL) of Key Manufacturers (2018-2024)
Table 5. Global Biopharma Buffer Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Biopharma Buffer Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Biopharma Buffer Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Biopharma Buffer Average Price (US$/L) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Biopharma Buffer, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Biopharma Buffer, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biopharma Buffer, Product Type & Application
Table 12. Global Key Manufacturers of Biopharma Buffer, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biopharma Buffer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Buffer as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biopharma Buffer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Biopharma Buffer Sales by Region (2018-2024) & (KL)
Table 18. Global Biopharma Buffer Sales Market Share by Region (2018-2024)
Table 19. Global Biopharma Buffer Sales by Region (2024-2029) & (KL)
Table 20. Global Biopharma Buffer Sales Market Share by Region (2024-2029)
Table 21. Global Biopharma Buffer Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Biopharma Buffer Revenue Market Share by Region (2018-2024)
Table 23. Global Biopharma Buffer Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Biopharma Buffer Revenue Market Share by Region (2024-2029)
Table 25. North America Biopharma Buffer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 27. North America Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 28. North America Biopharma Buffer Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Biopharma Buffer Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Biopharma Buffer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 32. Europe Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 33. Europe Biopharma Buffer Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Biopharma Buffer Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Biopharma Buffer Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Biopharma Buffer Sales by Region (2018-2024) & (KL)
Table 37. Asia Pacific Biopharma Buffer Sales by Region (2024-2029) & (KL)
Table 38. Asia Pacific Biopharma Buffer Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Biopharma Buffer Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Biopharma Buffer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 42. Latin America Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 43. Latin America Biopharma Buffer Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Biopharma Buffer Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Biopharma Buffer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 47. Middle East & Africa Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 48. Middle East & Africa Biopharma Buffer Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Biopharma Buffer Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Biopharma Buffer Sales (KL) by Type (2018-2024)
Table 51. Global Biopharma Buffer Sales (KL) by Type (2024-2029)
Table 52. Global Biopharma Buffer Sales Market Share by Type (2018-2024)
Table 53. Global Biopharma Buffer Sales Market Share by Type (2024-2029)
Table 54. Global Biopharma Buffer Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Biopharma Buffer Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Biopharma Buffer Revenue Market Share by Type (2018-2024)
Table 57. Global Biopharma Buffer Revenue Market Share by Type (2024-2029)
Table 58. Global Biopharma Buffer Price (US$/L) by Type (2018-2024)
Table 59. Global Biopharma Buffer Price (US$/L) by Type (2024-2029)
Table 60. Global Biopharma Buffer Sales (KL) by Application (2018-2024)
Table 61. Global Biopharma Buffer Sales (KL) by Application (2024-2029)
Table 62. Global Biopharma Buffer Sales Market Share by Application (2018-2024)
Table 63. Global Biopharma Buffer Sales Market Share by Application (2024-2029)
Table 64. Global Biopharma Buffer Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Biopharma Buffer Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Biopharma Buffer Revenue Market Share by Application (2018-2024)
Table 67. Global Biopharma Buffer Revenue Market Share by Application (2024-2029)
Table 68. Global Biopharma Buffer Price (US$/L) by Application (2018-2024)
Table 69. Global Biopharma Buffer Price (US$/L) by Application (2024-2029)
Table 70. Avantor Corporation Information
Table 71. Avantor Description and Business Overview
Table 72. Avantor Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 73. Avantor Biopharma Buffer Product
Table 74. Avantor Recent Developments/Updates
Table 75. Alfa Aesar (Thermo Fisher) Corporation Information
Table 76. Alfa Aesar (Thermo Fisher) Description and Business Overview
Table 77. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 78. Alfa Aesar (Thermo Fisher) Biopharma Buffer Product
Table 79. Alfa Aesar (Thermo Fisher) Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 83. Merck Biopharma Buffer Product
Table 84. Merck Recent Developments/Updates
Table 85. Lonza Corporation Information
Table 86. Lonza Description and Business Overview
Table 87. Lonza Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 88. Lonza Biopharma Buffer Product
Table 89. Lonza Recent Developments/Updates
Table 90. Bio-Rad Corporation Information
Table 91. Bio-Rad Description and Business Overview
Table 92. Bio-Rad Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 93. Bio-Rad Biopharma Buffer Product
Table 94. Bio-Rad Recent Developments/Updates
Table 95. BD Corporation Information
Table 96. BD Description and Business Overview
Table 97. BD Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 98. BD Biopharma Buffer Product
Table 99. BD Recent Developments/Updates
Table 100. GE Healthcare Corporation Information
Table 101. GE Healthcare Description and Business Overview
Table 102. GE Healthcare Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 103. GE Healthcare Biopharma Buffer Product
Table 104. GE Healthcare Recent Developments/Updates
Table 105. Promega Corporation Corporation Information
Table 106. Promega Corporation Description and Business Overview
Table 107. Promega Corporation Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 108. Promega Corporation Biopharma Buffer Product
Table 109. Promega Corporation Recent Developments/Updates
Table 110. Hamilton Company Corporation Information
Table 111. Hamilton Company Description and Business Overview
Table 112. Hamilton Company Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 113. Hamilton Company Biopharma Buffer Product
Table 114. Hamilton Company Recent Developments/Updates
Table 115. XZL BIO-TECHNOLOGY Corporation Information
Table 116. XZL BIO-TECHNOLOGY Description and Business Overview
Table 117. XZL BIO-TECHNOLOGY Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 118. XZL BIO-TECHNOLOGY Biopharma Buffer Product
Table 119. XZL BIO-TECHNOLOGY Recent Developments/Updates
Table 120. SRL Corporation Information
Table 121. SRL Description and Business Overview
Table 122. SRL Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 123. SRL Biopharma Buffer Product
Table 124. SRL Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Biopharma Buffer Distributors List
Table 128. Biopharma Buffer Customers List
Table 129. Biopharma Buffer Market Trends
Table 130. Biopharma Buffer Market Drivers
Table 131. Biopharma Buffer Market Challenges
Table 132. Biopharma Buffer Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biopharma Buffer
Figure 2. Global Biopharma Buffer Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Biopharma Buffer Market Share by Type in 2022 & 2029
Figure 4. Phosphates Type Product Picture
Figure 5. Acetates Type Product Picture
Figure 6. TRIS Type Product Picture
Figure 7. Others Product Picture
Figure 8. Global Biopharma Buffer Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Biopharma Buffer Market Share by Application in 2022 & 2029
Figure 10. Research Institution
Figure 11. Pharmaceutical Industry
Figure 12. Others
Figure 13. Global Biopharma Buffer Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Biopharma Buffer Market Size (2018-2029) & (US$ Million)
Figure 15. Global Biopharma Buffer Sales (2018-2029) & (KL)
Figure 16. Global Biopharma Buffer Average Price (US$/L) & (2018-2029)
Figure 17. Biopharma Buffer Report Years Considered
Figure 18. Biopharma Buffer Sales Share by Manufacturers in 2022
Figure 19. Global Biopharma Buffer Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Biopharma Buffer Players: Market Share by Revenue in 2022
Figure 21. Biopharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Biopharma Buffer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Biopharma Buffer Sales Market Share by Country (2018-2029)
Figure 24. North America Biopharma Buffer Revenue Market Share by Country (2018-2029)
Figure 25. United States Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Biopharma Buffer Sales Market Share by Country (2018-2029)
Figure 28. Europe Biopharma Buffer Revenue Market Share by Country (2018-2029)
Figure 29. Germany Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Biopharma Buffer Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Biopharma Buffer Revenue Market Share by Region (2018-2029)
Figure 36. China Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Biopharma Buffer Sales Market Share by Country (2018-2029)
Figure 46. Latin America Biopharma Buffer Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Biopharma Buffer Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Biopharma Buffer Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Biopharma Buffer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Biopharma Buffer by Type (2018-2029)
Figure 56. Global Revenue Market Share of Biopharma Buffer by Type (2018-2029)
Figure 57. Global Biopharma Buffer Price (US$/L) by Type (2018-2029)
Figure 58. Global Sales Market Share of Biopharma Buffer by Application (2018-2029)
Figure 59. Global Revenue Market Share of Biopharma Buffer by Application (2018-2029)
Figure 60. Global Biopharma Buffer Price (US$/L) by Application (2018-2029)
Figure 61. Biopharma Buffer Value Chain
Figure 62. Biopharma Buffer Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries